Literature DB >> 17589381

Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients.

David J Klein1, Anastasia Derzko, Debra Foster, Andrew J E Seely, Fabrice Brunet, Alexander D Romaschin, John C Marshall.   

Abstract

High blood levels of endotoxin on admission to the intensive care unit are predictive of adverse outcomes, including organ failure and death. However, the significance of changes in endotoxin levels over time has not been evaluated. We examined whether dynamic daily changes in endotoxin levels resulted in the development of greater organ dysfunction over time in critically ill patients. The study was a retrospective analysis of data from the longitudinal phase of a prospective observational multicenter cohort study of endotoxin levels in patients admitted to the intensive care unit. We analyzed 345 patients. Daily variation in endotoxin levels was assessed by calculating the number of inflections in the curve generated by plotting endotoxin levels against time. The degree of organ dysfunction over time was analyzed using a calculation of the total area under the curve generated by plotting the Multi Organ Dysfunction Score against time. From 1,301 endotoxin activity assay results, patients with dynamic daily variation in endotoxin levels as measured by a greater number of inflections had a greater degree of total organ dysfunction as measured by Multi Organ Dysfunction Score against time (P < 0.05). The arithmetic mean standard deviation of endotoxin activity assay results increased stepwise in the zero, one, and two inflection groups supporting the association between inflections and variability. Endotoxin activity assay variability was found to be independent of infection status (P = 0.52). Daily dynamic variation in endotoxin levels is a marker of increased severity of illness as measured by burden of total organ dysfunction over time. Further studies are warranted to assess the role of daily variation in endotoxin levels in the pathogenesis and potential therapy of organ failure in the critically ill.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589381     DOI: 10.1097/shk.0b013e31805363c6

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  14 in total

1.  Effect of empiric antibiotic treatment on plasma endotoxin activity in septic patients.

Authors:  F Mignon; M Piagnerelli; M Van Nuffelen; J L Vincent
Journal:  Infection       Date:  2014-01-28       Impact factor: 3.553

2.  Validation of postinjury multiple organ failure scores.

Authors:  Angela Sauaia; Ernest E Moore; Jeffrey L Johnson; David J Ciesla; Walter L Biffl; Anirban Banerjee
Journal:  Shock       Date:  2009-05       Impact factor: 3.454

3.  Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.

Authors:  R Phillip Dellinger; Sean M Bagshaw; Massimo Antonelli; Debra M Foster; David J Klein; John C Marshall; Paul M Palevsky; Lawrence S Weisberg; Christa A Schorr; Stephen Trzeciak; Paul M Walker
Journal:  JAMA       Date:  2018-10-09       Impact factor: 56.272

Review 4.  Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders.

Authors:  James C Hurley; Bertrand Guidet; Georges Offenstadt; Eric Maury
Journal:  Crit Care       Date:  2012-08-07       Impact factor: 9.097

5.  Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational study.

Authors:  Arino Yaguchi; Junji Yuzawa; David J Klein; Munekasu Takeda; Tomoyuki Harada
Journal:  Crit Care       Date:  2012-05-18       Impact factor: 9.097

Review 6.  Polymyxin B hemoperfusion: a mechanistic perspective.

Authors:  Claudio Ronco; David J Klein
Journal:  Crit Care       Date:  2014-06-09       Impact factor: 9.097

7.  Wnt-Signaling Inhibitor Wnt-C59 Suppresses the Cytokine Upregulation in Multiple Organs of Lipopolysaccharide-Induced Endotoxemic Mice via Reducing the Interaction between β-Catenin and NF-κB.

Authors:  Jaewoong Jang; Jaewon Song; Inae Sim; Young V Kwon; Yoosik Yoon
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

Review 8.  Bench-to-bedside review: Clinical experience with the endotoxin activity assay.

Authors:  Alexander D Romaschin; David J Klein; John C Marshall
Journal:  Crit Care       Date:  2012-12-03       Impact factor: 9.097

9.  Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery.

Authors:  Michail Yaroustovsky; Marina Plyushch; Dmitry Popov; Natalia Samsonova; Marina Abramyan; Zakhar Popok; Nickolay Krotenko
Journal:  J Inflamm (Lond)       Date:  2013-03-06       Impact factor: 4.981

10.  The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.

Authors:  David J Klein; Debra Foster; Christa A Schorr; Kazem Kazempour; Paul M Walker; R Phillip Dellinger
Journal:  Trials       Date:  2014-06-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.